Short Interest in CBD Life Sciences Inc. (OTCMKTS:CBDL) Declines By 88.3%

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 39,500 shares, a drop of 88.3% from the December 31st total of 338,600 shares. Based on an average daily trading volume, of 75,074,700 shares, the days-to-cover ratio is currently 0.0 days.

CBD Life Sciences Stock Performance

OTCMKTS:CBDL opened at $0.00 on Wednesday. CBD Life Sciences has a one year low of $0.00 and a one year high of $0.03.

About CBD Life Sciences

(Get Free Report)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

Further Reading

Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.